BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 6, 2018
View Archived Issues
Inhibiting mitochondrial RTK is breast cancer target
Read More
Protein-tyrosine kinase 2 identified as a therapeutic target for Kawasaki disease
Read More
Colorectal cancer stem cells are made, not born: study
Read More
Kineta starts first-in-human study of LHF-535
Read More
Proof-of-concept data presented from PHYOX phase I study of DCR-PHXC in primary hyperoxaluria
Read More
LEAPS rheumatoid arthritis vaccine selected for commercialization accelerator program
Read More
PLAG1 overexpression induces Wilms tumor formation and correlates with early relapse in patients
Read More
Phase III study of NeoCart in patients with knee cartilage damage does not meet the primary endpoint
Read More
GT-73 demonstrates efficacy in various in vivo models
Read More
Phase I/II results with pegzilarginase in arginase deficiency support upcoming pivotal trial
Read More
CB-59 and CB-81, two small-molecule tau aggregation inhibitors with CNS drug-like properties
Read More
Phase I/II interim data on QR-110 in LCA10 support progression to phase II/III
Read More
Summit Therapeutics names lead clinical candidate for gonorrhea
Read More
Daewoong Pharmaceutical patents EPRS inhibitors
Read More
Argenx initiates phase III trial of efgartigimod in generalized myasthenia gravis
Read More
Enanta Pharmaceuticals divulges new NR1H4 agonists
Read More
OncoArendi Therapeutics presents new AMCase and CHIT1 dual inhibitors for lung diseases
Read More
Adocia reports phase I data on BioChaperone Pramlintide Insulin in type 1 diabetes
Read More
AIC-649 stimulates the immune system of patients with chronic HBV in phase I trial
Read More
DSMB recommends continuation of phase IIb study of OPT-302 in wet AMD
Read More
Phoenix PharmaLabs receives support to study PPL-103 for cocaine addiction
Read More
Phase III study of PET imaging agent flortaucipir F 18 meets primary endpoints
Read More
Phase II TORTUGA trial of filgotinib in ankylosing spondylitis meets primary efficacy endpoint
Read More
Poseida notes data from ongoing phase I study of P-BCMA-101 in relapsed/refractory multiple myeloma
Read More
